About This Study
The purpose of this study is to learn more about a new study drug called Lutikizumab. We want to see if this study drug is safe and works well for treating moderate to severe ulcerative colitis. We will compare this study drug to another drug called Adalimumab.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 18 - 100 years old
- All Genders
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC